Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tianling Chen

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Materials Today. Bio|November 13, 2024
Engineering exosomes from fibroblast growth factor 1 pre-conditioned adipose-derived stem cells promote ischemic skin flaps survival by activating autophagyXuanlong Zhang, Xiaoqiong Jiang, Huiming Deng, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 13, 2003
86Y-DOTA0)-D-Phe1-Tyr3-octreotide (SMT487)--a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusionFrançois Jamar, Raffaella Barone, Isabelle Mathieu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Phase I and pharmacologic study of SNS-032, a potent and selective Cdk2, 7, and 9 inhibitor, in patients with advanced chronic lymphocytic leukemia and multiple myelomaWei-Gang Tong, Rong Chen, William Plunkett, et al.
Haematologica|November 9, 2014
A phase 1b/2 study of vosaroxin in combination with cytarabine in patients with relapsed or refractory acute myeloid leukemiaJeffrey E Lancet, Gail J Roboz, Larry D Cripe, et al.
Bioconjugate Chemistry|March 16, 2006
Characterization of a CC49-based single-chain fragment-beta-lactamase fusion protein for antibody-directed enzyme prodrug therapy (ADEPT)Ralph F Alderson, Brian E Toki, Martin Roberge, et al.
BMC Medicine|April 18, 2025
The role of environmental access to exercise opportunities in cardiovascular mortality: evidence from a nationwide studyXiaowen Wang, Yongshi Gu, Ying Wang, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Materials Today. Bio|November 13, 2024
Engineering exosomes from fibroblast growth factor 1 pre-conditioned adipose-derived stem cells promote ischemic skin flaps survival by activating autophagyXuanlong Zhang, Xiaoqiong Jiang, Huiming Deng, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 13, 2003
86Y-DOTA0)-D-Phe1-Tyr3-octreotide (SMT487)--a phase 1 clinical study: pharmacokinetics, biodistribution and renal protective effect of different regimens of amino acid co-infusionFrançois Jamar, Raffaella Barone, Isabelle Mathieu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Phase I and pharmacologic study of SNS-032, a potent and selective Cdk2, 7, and 9 inhibitor, in patients with advanced chronic lymphocytic leukemia and multiple myelomaWei-Gang Tong, Rong Chen, William Plunkett, et al.
Haematologica|November 9, 2014
A phase 1b/2 study of vosaroxin in combination with cytarabine in patients with relapsed or refractory acute myeloid leukemiaJeffrey E Lancet, Gail J Roboz, Larry D Cripe, et al.
Bioconjugate Chemistry|March 16, 2006
Characterization of a CC49-based single-chain fragment-beta-lactamase fusion protein for antibody-directed enzyme prodrug therapy (ADEPT)Ralph F Alderson, Brian E Toki, Martin Roberge, et al.
BMC Medicine|April 18, 2025
The role of environmental access to exercise opportunities in cardiovascular mortality: evidence from a nationwide studyXiaowen Wang, Yongshi Gu, Ying Wang, et al.
Pageof 2